Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds Penn In the News Politifact Immunity from COVID-19 infection is strong and lasting, but carries risks, research finds According to John Wherry of the Perelman School of Medicine, it’s not surprising that SARS-CoV-2 infection generates robust immunity, including protection from disease. Vaccine makers are preparing for bird flu Penn In the News Scientific American Vaccine makers are preparing for bird flu Scott Hensley of the Perelman School of Medicine and colleagues are developing and testing a vaccine tailored to the current bird flu strain based on their previous 20-subtype mRNA flu vaccine. Avian flu strain raises concerns after outbreaks among mammals Penn In the News PBS NewsHour Avian flu strain raises concerns after outbreaks among mammals Scott Hensley of the Perelman School of Medicine discusses the highly contagious avian flu ravaging the globe and how outbreaks in some mammals are a cause for concern. An even deadlier pandemic could soon be here Penn In the News The New York Times An even deadlier pandemic could soon be here Scott Hensley of the Perelman School of Medicine says that mRNA vaccines can be mass-produced faster than normal, in as little as three months. Five ways Gov. Josh Shapiro can boost Pennsylvania’s innovation economy Penn In the News Philadelphia Inquirer Five ways Gov. Josh Shapiro can boost Pennsylvania’s innovation economy Carl June of the Perelman School of Medicine is noted as an example of how innovative research can create business ecosystems. Harnessing an innate protection against Ebola An innate mechanism in human cells may prevent Ebola virus from spreading, according to new Penn Vet-led research. Using powerful confocal microscopy, they tracked the budding of virus-like particles from cells (shown in the filamentous projections in the cell in the upper right) and how autophagy, a “self-eating” cellular process, by which viral proteins are sequestered in vesicles (shown in the cell in the lower left), inhibits virus-like particles from exiting. (Image: Courtesy of the Harty lab) Harnessing an innate protection against Ebola School of Veterinary Medicine researchers have identified a cellular pathway that keeps Ebola virus from exiting human cells, with implications for developing new antivirals. Five things to know about this year’s ‘tripledemic’ Image: iStock/Srdjanns74 Five things to know about this year’s ‘tripledemic’ The Perelman School of Medicine’s E. John Wherry and Scott Hensley discuss the season’s confluence of COVID-19, influenza, and RSV and how our bodies are responding. The race to supercharge cancer-fighting T cells Penn In the News Nature The race to supercharge cancer-fighting T cells Carl June and Avery Posey of the Perelman School of Medicine discuss the progression and expansion of CAR-T cell therapies. CAR T cell therapy may eliminate tumor cells missed by surgery CAR T cell therapy may eliminate tumor cells missed by surgery The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells. What’s next for mRNA vaccines Penn In the News MIT Technology Review What’s next for mRNA vaccines Norbert Pardi of the Perelman School of Medicine and colleagues are developing a universal mRNA flu vaccine, featuring remarks from mRNA pioneer Katalin Karikó. Load More
Vaccine makers are preparing for bird flu Penn In the News Scientific American Vaccine makers are preparing for bird flu Scott Hensley of the Perelman School of Medicine and colleagues are developing and testing a vaccine tailored to the current bird flu strain based on their previous 20-subtype mRNA flu vaccine. Avian flu strain raises concerns after outbreaks among mammals Penn In the News PBS NewsHour Avian flu strain raises concerns after outbreaks among mammals Scott Hensley of the Perelman School of Medicine discusses the highly contagious avian flu ravaging the globe and how outbreaks in some mammals are a cause for concern. An even deadlier pandemic could soon be here Penn In the News The New York Times An even deadlier pandemic could soon be here Scott Hensley of the Perelman School of Medicine says that mRNA vaccines can be mass-produced faster than normal, in as little as three months. Five ways Gov. Josh Shapiro can boost Pennsylvania’s innovation economy Penn In the News Philadelphia Inquirer Five ways Gov. Josh Shapiro can boost Pennsylvania’s innovation economy Carl June of the Perelman School of Medicine is noted as an example of how innovative research can create business ecosystems. Harnessing an innate protection against Ebola An innate mechanism in human cells may prevent Ebola virus from spreading, according to new Penn Vet-led research. Using powerful confocal microscopy, they tracked the budding of virus-like particles from cells (shown in the filamentous projections in the cell in the upper right) and how autophagy, a “self-eating” cellular process, by which viral proteins are sequestered in vesicles (shown in the cell in the lower left), inhibits virus-like particles from exiting. (Image: Courtesy of the Harty lab) Harnessing an innate protection against Ebola School of Veterinary Medicine researchers have identified a cellular pathway that keeps Ebola virus from exiting human cells, with implications for developing new antivirals. Five things to know about this year’s ‘tripledemic’ Image: iStock/Srdjanns74 Five things to know about this year’s ‘tripledemic’ The Perelman School of Medicine’s E. John Wherry and Scott Hensley discuss the season’s confluence of COVID-19, influenza, and RSV and how our bodies are responding. The race to supercharge cancer-fighting T cells Penn In the News Nature The race to supercharge cancer-fighting T cells Carl June and Avery Posey of the Perelman School of Medicine discuss the progression and expansion of CAR-T cell therapies. CAR T cell therapy may eliminate tumor cells missed by surgery CAR T cell therapy may eliminate tumor cells missed by surgery The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells. What’s next for mRNA vaccines Penn In the News MIT Technology Review What’s next for mRNA vaccines Norbert Pardi of the Perelman School of Medicine and colleagues are developing a universal mRNA flu vaccine, featuring remarks from mRNA pioneer Katalin Karikó. Load More
Avian flu strain raises concerns after outbreaks among mammals Penn In the News PBS NewsHour Avian flu strain raises concerns after outbreaks among mammals Scott Hensley of the Perelman School of Medicine discusses the highly contagious avian flu ravaging the globe and how outbreaks in some mammals are a cause for concern. An even deadlier pandemic could soon be here Penn In the News The New York Times An even deadlier pandemic could soon be here Scott Hensley of the Perelman School of Medicine says that mRNA vaccines can be mass-produced faster than normal, in as little as three months. Five ways Gov. Josh Shapiro can boost Pennsylvania’s innovation economy Penn In the News Philadelphia Inquirer Five ways Gov. Josh Shapiro can boost Pennsylvania’s innovation economy Carl June of the Perelman School of Medicine is noted as an example of how innovative research can create business ecosystems. Harnessing an innate protection against Ebola An innate mechanism in human cells may prevent Ebola virus from spreading, according to new Penn Vet-led research. Using powerful confocal microscopy, they tracked the budding of virus-like particles from cells (shown in the filamentous projections in the cell in the upper right) and how autophagy, a “self-eating” cellular process, by which viral proteins are sequestered in vesicles (shown in the cell in the lower left), inhibits virus-like particles from exiting. (Image: Courtesy of the Harty lab) Harnessing an innate protection against Ebola School of Veterinary Medicine researchers have identified a cellular pathway that keeps Ebola virus from exiting human cells, with implications for developing new antivirals. Five things to know about this year’s ‘tripledemic’ Image: iStock/Srdjanns74 Five things to know about this year’s ‘tripledemic’ The Perelman School of Medicine’s E. John Wherry and Scott Hensley discuss the season’s confluence of COVID-19, influenza, and RSV and how our bodies are responding. The race to supercharge cancer-fighting T cells Penn In the News Nature The race to supercharge cancer-fighting T cells Carl June and Avery Posey of the Perelman School of Medicine discuss the progression and expansion of CAR-T cell therapies. CAR T cell therapy may eliminate tumor cells missed by surgery CAR T cell therapy may eliminate tumor cells missed by surgery The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells. What’s next for mRNA vaccines Penn In the News MIT Technology Review What’s next for mRNA vaccines Norbert Pardi of the Perelman School of Medicine and colleagues are developing a universal mRNA flu vaccine, featuring remarks from mRNA pioneer Katalin Karikó. Load More
An even deadlier pandemic could soon be here Penn In the News The New York Times An even deadlier pandemic could soon be here Scott Hensley of the Perelman School of Medicine says that mRNA vaccines can be mass-produced faster than normal, in as little as three months. Five ways Gov. Josh Shapiro can boost Pennsylvania’s innovation economy Penn In the News Philadelphia Inquirer Five ways Gov. Josh Shapiro can boost Pennsylvania’s innovation economy Carl June of the Perelman School of Medicine is noted as an example of how innovative research can create business ecosystems. Harnessing an innate protection against Ebola An innate mechanism in human cells may prevent Ebola virus from spreading, according to new Penn Vet-led research. Using powerful confocal microscopy, they tracked the budding of virus-like particles from cells (shown in the filamentous projections in the cell in the upper right) and how autophagy, a “self-eating” cellular process, by which viral proteins are sequestered in vesicles (shown in the cell in the lower left), inhibits virus-like particles from exiting. (Image: Courtesy of the Harty lab) Harnessing an innate protection against Ebola School of Veterinary Medicine researchers have identified a cellular pathway that keeps Ebola virus from exiting human cells, with implications for developing new antivirals. Five things to know about this year’s ‘tripledemic’ Image: iStock/Srdjanns74 Five things to know about this year’s ‘tripledemic’ The Perelman School of Medicine’s E. John Wherry and Scott Hensley discuss the season’s confluence of COVID-19, influenza, and RSV and how our bodies are responding. The race to supercharge cancer-fighting T cells Penn In the News Nature The race to supercharge cancer-fighting T cells Carl June and Avery Posey of the Perelman School of Medicine discuss the progression and expansion of CAR-T cell therapies. CAR T cell therapy may eliminate tumor cells missed by surgery CAR T cell therapy may eliminate tumor cells missed by surgery The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells. What’s next for mRNA vaccines Penn In the News MIT Technology Review What’s next for mRNA vaccines Norbert Pardi of the Perelman School of Medicine and colleagues are developing a universal mRNA flu vaccine, featuring remarks from mRNA pioneer Katalin Karikó. Load More
Five ways Gov. Josh Shapiro can boost Pennsylvania’s innovation economy Penn In the News Philadelphia Inquirer Five ways Gov. Josh Shapiro can boost Pennsylvania’s innovation economy Carl June of the Perelman School of Medicine is noted as an example of how innovative research can create business ecosystems. Harnessing an innate protection against Ebola An innate mechanism in human cells may prevent Ebola virus from spreading, according to new Penn Vet-led research. Using powerful confocal microscopy, they tracked the budding of virus-like particles from cells (shown in the filamentous projections in the cell in the upper right) and how autophagy, a “self-eating” cellular process, by which viral proteins are sequestered in vesicles (shown in the cell in the lower left), inhibits virus-like particles from exiting. (Image: Courtesy of the Harty lab) Harnessing an innate protection against Ebola School of Veterinary Medicine researchers have identified a cellular pathway that keeps Ebola virus from exiting human cells, with implications for developing new antivirals. Five things to know about this year’s ‘tripledemic’ Image: iStock/Srdjanns74 Five things to know about this year’s ‘tripledemic’ The Perelman School of Medicine’s E. John Wherry and Scott Hensley discuss the season’s confluence of COVID-19, influenza, and RSV and how our bodies are responding. The race to supercharge cancer-fighting T cells Penn In the News Nature The race to supercharge cancer-fighting T cells Carl June and Avery Posey of the Perelman School of Medicine discuss the progression and expansion of CAR-T cell therapies. CAR T cell therapy may eliminate tumor cells missed by surgery CAR T cell therapy may eliminate tumor cells missed by surgery The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells. What’s next for mRNA vaccines Penn In the News MIT Technology Review What’s next for mRNA vaccines Norbert Pardi of the Perelman School of Medicine and colleagues are developing a universal mRNA flu vaccine, featuring remarks from mRNA pioneer Katalin Karikó. Load More
Harnessing an innate protection against Ebola An innate mechanism in human cells may prevent Ebola virus from spreading, according to new Penn Vet-led research. Using powerful confocal microscopy, they tracked the budding of virus-like particles from cells (shown in the filamentous projections in the cell in the upper right) and how autophagy, a “self-eating” cellular process, by which viral proteins are sequestered in vesicles (shown in the cell in the lower left), inhibits virus-like particles from exiting. (Image: Courtesy of the Harty lab) Harnessing an innate protection against Ebola School of Veterinary Medicine researchers have identified a cellular pathway that keeps Ebola virus from exiting human cells, with implications for developing new antivirals.
Five things to know about this year’s ‘tripledemic’ Image: iStock/Srdjanns74 Five things to know about this year’s ‘tripledemic’ The Perelman School of Medicine’s E. John Wherry and Scott Hensley discuss the season’s confluence of COVID-19, influenza, and RSV and how our bodies are responding.
The race to supercharge cancer-fighting T cells Penn In the News Nature The race to supercharge cancer-fighting T cells Carl June and Avery Posey of the Perelman School of Medicine discuss the progression and expansion of CAR-T cell therapies. CAR T cell therapy may eliminate tumor cells missed by surgery CAR T cell therapy may eliminate tumor cells missed by surgery The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells. What’s next for mRNA vaccines Penn In the News MIT Technology Review What’s next for mRNA vaccines Norbert Pardi of the Perelman School of Medicine and colleagues are developing a universal mRNA flu vaccine, featuring remarks from mRNA pioneer Katalin Karikó. Load More
CAR T cell therapy may eliminate tumor cells missed by surgery CAR T cell therapy may eliminate tumor cells missed by surgery The results of a study led by Penn Medicine’s Carl June greenlights preclinical trials for the application of CAR T therapy in gel form to surgical wounds following partial tumor removal to eliminate residual tumor cells.
What’s next for mRNA vaccines Penn In the News MIT Technology Review What’s next for mRNA vaccines Norbert Pardi of the Perelman School of Medicine and colleagues are developing a universal mRNA flu vaccine, featuring remarks from mRNA pioneer Katalin Karikó.